Safety Shot Inc (SHOT)
USD 0.45
(7.25%)
USD 0.45
(7.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.86 Million USD | 323.57% |
| 2022 | 441.4 Thousand USD | 45.07% |
| 2021 | 304.26 Thousand USD | 34.68% |
| 2020 | 225.92 Thousand USD | 66.76% |
| 2019 | 135.47 Thousand USD | 551.59% |
| 2018 | -30 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 403.76 Thousand USD | -49.26% |
| 2024 Q2 | 739.43 Thousand USD | 83.14% |
| 2023 Q3 | 93.66 Thousand USD | -71.47% |
| 2023 Q1 | 265.87 Thousand USD | -39.77% |
| 2023 Q2 | 328.32 Thousand USD | 23.49% |
| 2023 FY | 795.82 Thousand USD | 80.29% |
| 2023 Q4 | 795.82 Thousand USD | 749.67% |
| 2022 Q1 | 473.13 Thousand USD | 55.5% |
| 2022 FY | 441.4 Thousand USD | 45.07% |
| 2022 Q4 | 441.4 Thousand USD | 11.11% |
| 2022 Q3 | 397.27 Thousand USD | 2.4% |
| 2022 Q2 | 387.96 Thousand USD | -18.0% |
| 2021 Q2 | 255.06 Thousand USD | 2.3% |
| 2021 Q3 | 637.03 Thousand USD | 149.76% |
| 2021 Q4 | 304.26 Thousand USD | -52.24% |
| 2021 FY | 304.26 Thousand USD | 34.68% |
| 2021 Q1 | 249.32 Thousand USD | 10.36% |
| 2020 Q4 | 225.92 Thousand USD | -23.12% |
| 2020 Q2 | 258.55 Thousand USD | 56.99% |
| 2020 Q1 | 164.69 Thousand USD | 21.56% |
| 2020 FY | 225.92 Thousand USD | 66.76% |
| 2020 Q3 | 293.85 Thousand USD | 13.65% |
| 2019 FY | 135.47 Thousand USD | 551.59% |
| 2019 Q4 | 135.47 Thousand USD | 0.0% |
| 2019 Q2 | 59.39 Thousand USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 FY | -30 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Bright Green Corporation | - USD | -Infinity% |
| Alpha Teknova, Inc. | 11.59 Million USD | 83.874% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 98.319% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | 72.379% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 94.217% |
| Cosmos Health Inc. | 4.78 Million USD | 60.96% |
| Journey Medical Corporation | 10.2 Million USD | 81.681% |
| Embecta Corp. | 152.1 Million USD | 98.771% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 97.151% |
| Dynavax Technologies Corporation | 53.29 Million USD | 96.492% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | 83.947% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 98.208% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 67.398% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | 67.398% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -130.89% |
| Procaps Group, S.A. | 96.83 Million USD | 98.069% |
| Theratechnologies Inc. | 6.06 Million USD | 69.178% |
| Harrow Health, Inc. | 10.86 Million USD | 82.795% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | 31.238% |
| Biofrontera Inc. | 10.9 Million USD | 82.86% |
| DURECT Corporation | 2.21 Million USD | 15.744% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 97.585% |
| Cronos Group Inc. | 30.33 Million USD | 93.837% |
| OptiNose, Inc. | 8.05 Million USD | 76.78% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -186964600.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | 67.194% |
| Organogenesis Holdings Inc. | 28.25 Million USD | 93.382% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | 30.162% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | 59.438% |
| Radius Health, Inc. | 278.64 Million USD | 99.329% |
| Universe Pharmaceuticals INC | 3.34 Million USD | 44.077% |
| ProPhase Labs, Inc. | 3.84 Million USD | 51.324% |
| Phibro Animal Health Corporation | 265.91 Million USD | 99.297% |
| Procaps Group S.A. | 96.83 Million USD | 98.069% |
| Alvotech | 74.43 Million USD | 97.488% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.946% |
| Rockwell Medical, Inc. | 5.87 Million USD | 68.155% |
| Aytu BioPharma, Inc. | 12.63 Million USD | 85.2% |
| SIGA Technologies, Inc. | 64.21 Million USD | 97.089% |
| Tilray Brands, Inc. | 252.08 Million USD | 99.258% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 95.323% |
| Shineco, Inc. | 1.58 Million USD | -17.697% |
| PetIQ, Inc. | 159.3 Million USD | 98.826% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 1323.767% |
| Incannex Healthcare Limited | -10.01 Million USD | 118.668% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 95.118% |
| Alimera Sciences, Inc. | 1.87 Million USD | 0.498% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 95.039% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -16.099% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | 58.295% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -635.063% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | 81.988% |
| Hempacco Co., Inc. | 2.54 Million USD | 26.468% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 97.488% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 96.088% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 97.08% |
| Currenc Group, Inc. | 732.91 Thousand USD | -155.099% |
| Kamada Ltd. | 87.74 Million USD | 97.869% |
| Indivior PLC | 141.79 Million USD | 98.681% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -288.022% |
| Flora Growth Corp. | 8.5 Million USD | 78.025% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -635.063% |
| Evolus, Inc. | 10.99 Million USD | 83.0% |
| HUTCHMED (China) Limited | 50.25 Million USD | 96.28% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 98.233% |
| Akanda Corp. | 1.28 Million USD | -45.284% |